First Nebraska Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.3M Sell
66,544
-84
-0.1% -$19.6K 1.5% 15
2025
Q4
$13.8M Sell
66,628
-279
-0.4% -$55.2K 1.26% 18
2025
Q3
$12.4M Sell
66,907
-292
-0.4% -$50K 1.12% 21
2025
Q2
$10.3M Sell
67,199
-390
-0.6% -$59.9K 0.98% 27
2025
Q1
$11.2M Buy
67,589
+4,210
+7% +$659K 1.11% 23
2024
Q4
$9.17M Sell
63,379
-5,425
-8% -$841K 0.89% 31
2024
Q3
$11.2M Sell
68,804
-892
-1% -$142K 1.08% 21
2024
Q2
$10.2M Sell
69,696
-474
-0.7% -$70.5K 1.05% 22
2024
Q1
$11.1M Sell
70,170
-898
-1% -$143K 1.15% 20
2023
Q4
$11.1M Buy
71,068
+1,365
+2% +$209K 1.29% 17
2023
Q3
$10.9M Buy
69,703
+771
+1% +$127K 1.35% 18
2023
Q2
$11.4M Buy
68,932
+231
+0.3% +$37.3K 1.36% 16
2023
Q1
$10.6M Buy
68,701
+75
+0.1% +$12.1K 1.34% 16
2022
Q4
$12.1M Sell
68,626
-656
-0.9% -$113K 1.58% 13
2022
Q3
$11.3M Buy
69,282
+1,840
+3% +$311K 1.62% 14
2022
Q2
$12M Sell
67,442
-230
-0.3% -$41K 1.57% 13
2022
Q1
$12M Buy
67,672
+339
+0.5% +$57.7K 1.42% 15
2021
Q4
$11.5M Buy
67,333
+710
+1% +$116K 1.39% 15
2021
Q3
$10.8M Sell
66,623
-73
-0.1% -$12.5K 1.41% 15
2021
Q2
$11M Buy
66,696
+1,007
+2% +$167K 1.43% 15
2021
Q1
$10.8M Buy
65,689
+2,940
+5% +$476K 1.45% 15
2020
Q4
$9.88M Sell
62,749
-124
-0.2% -$18.3K 1.43% 17
2020
Q3
$9.36M Sell
62,873
-1,051
-2% -$156K 1.6% 15
2020
Q2
$8.99M Sell
63,924
-1,484
-2% -$216K 1.66% 14
2020
Q1
$8.58M Buy
65,408
+4,716
+8% +$669K 1.89% 11
2019
Q4
$8.85M Sell
60,692
-364
-0.6% -$49.4K 1.44% 15
2019
Q3
$7.9M Buy
61,056
+1,131
+2% +$149K 1.31% 15
2019
Q2
$8.35M Sell
59,925
-427
-0.7% -$59.1K 1.46% 15
2019
Q1
$8.44M Buy
60,352
+1,744
+3% +$234K 1.52% 12
2018
Q4
$7.56M Sell
58,608
-316
-0.5% -$44.1K 1.54% 11
2018
Q3
$8.14M Sell
58,924
-560
-0.9% -$74.4K 1.38% 9
2018
Q2
$7.22M Buy
59,484
+8,350
+16% +$1.04M 1.55% 13
2018
Q1
$6.55M Buy
51,134
+302
+0.6% +$40.8K 1.3% 17
2017
Q4
$7.1M Sell
50,832
-1,043
-2% -$145K 1.45% 13
2017
Q3
$6.74M Sell
51,875
-575
-1% -$76.2K 1.48% 13
2017
Q2
$6.94M Sell
52,450
-733
-1% -$93.5K 1.56% 13
2017
Q1
$6.62M Buy
53,183
+633
+1% +$75.6K 1.48% 14
2016
Q4
$6.05M Sell
52,550
-19
-0% -$2.19K 1.45% 15
2016
Q3
$6.21M Sell
52,569
-321
-0.6% -$38.9K 1.6% 13
2016
Q2
$6.42M Buy
52,890
+401
+0.8% +$45.6K 1.67% 12
2016
Q1
$5.68M Buy
52,489
+2,388
+5% +$247K 1.56% 14
2015
Q4
$5.15M Buy
50,101
+6,885
+16% +$692K 1.55% 18
2015
Q3
$4.03M Sell
43,216
-31
-0.1% -$3K 1.28% 20
2015
Q2
$4.21M Sell
43,247
-1,086
-2% -$109K 1.29% 24
2015
Q1
$4.46M Hold
44,333
1.31% 22
2014
Q4
$4.64M Sell
44,333
-2,725
-6% -$287K 1.34% 23
2014
Q3
$5.02M Sell
47,058
-2,232
-5% -$231K 1.43% 21
2014
Q2
$5.16M Sell
49,290
-552
-1% -$55.8K 1.48% 20
2014
Q1
$4.9M Buy
49,842
+15
+0% +$1.39K 1.51% 20
2013
Q4
$4.56M Sell
49,827
-1,358
-3% -$125K 1.43% 18
2013
Q3
$4.44M Buy
+51,185
New +$4.59M 1.54% 17

Other funds holding JNJ

First Nebraska Trust's JNJ Position: Q1 2026 in Review

First Nebraska Trust reduced its Johnson & Johnson (JNJ) stake by 0.13% in Q1 2026, selling an estimated $19.6K and leaving 66,544 shares worth $16.3M. The position accounts for 1.5% of the portfolio, ranked #15.

First Nebraska Trust first reported a position in JNJ in Q3 2013 and has held it in 51 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • First Nebraska Trust held 66,544 shares of Johnson & Johnson worth $16.3M as of Q1 2026.
  • First Nebraska Trust sold 84 Johnson & Johnson shares in Q1 2026, an estimated $19.6K.
  • Johnson & Johnson made up 1.5% of First Nebraska Trust's portfolio in Q1 2026, its #15 holding.
  • First Nebraska Trust first reported a position in Johnson & Johnson in Q3 2013 and has held it in 51 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.